Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.8.0.1
Stock-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2017
Stockholders' Equity.  
Summary of stock-based compensation expense by statement of operations line item

The following table summarizes, by statement of operations line item, stock-based compensation expense for the Company’s three and nine months ended December 31, 2017 and 2016 (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

December 31,

 

December 31,

 

 

    

2017

    

2016

    

2017

    

2016

 

Cost of goods sold

 

$

 —

    

$

16

 

$

38

    

$

45

 

Research and development

 

 

 4

 

 

 6

 

 

16

 

 

22

 

Selling, general and administrative

 

 

98

 

 

152

 

 

355

 

 

586

 

Stock-based compensation expense

 

$

102

 

$

174

 

$

409

 

$

653

 

 

Summary of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

Aggregate

 

 

 

 

 

Average

 

Contractual

 

Intrinsic

 

 

 

Shares

 

Exercise Price

 

Term

 

Value

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

Options outstanding at March 31, 2017

    

314,537

    

$

15.48

    

 

    

 

 

 

Granted

 

 —

 

$

 —

 

 

 

 

 

 

Exercised

 

 —

 

$

 —

 

 

 

 

 

 

Forfeited, cancelled or expired

 

(97,590)

 

$

3.68

 

 

 

 

 

 

Options outstanding at December 31, 2017

 

216,947

 

$

20.79

 

3.0

 

 

 —

 

Options fully vested at December 31, 2017 and those expected to vest beyond December 31, 2017

 

216,947

 

$

20.79

 

3.0

 

 

 —

 

Options exercisable at December 31, 2017

 

216,947

 

$

20.79

 

3.0

 

 

 —

 

 

Schedule of weighted-average assumptions used to calculate the estimated fair value of each stock option

 

 

 

 

 

 

 

Three and Nine Months Ended

 

 

December 31, 2016

Risk-free interest rates

 

 

1.3

%  

Expected lives (in years)

 

 

5.7

 

Dividend yield

 

 

 —

%  

Expected volatility

 

 

133.9

%  

Weighted average grant date fair value of options granted during the period

 

$

1.52

 

 

Summary of restricted stock unit and performance restricted stock unit activity

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average Grant

 

 

 

 

 

Date Fair

 

Restricted Stock and Performance Restricted Stock Units

 

Shares

 

Value

 

Nonvested restricted stock units outstanding at March 31, 2017

    

316,709

    

$

2.85

 

Granted

 

909,848

 

 

0.76

 

Vested and issued

 

(239,372)

 

 

2.63

 

Forfeited

 

(46,168)

 

 

1.79

 

Nonvested restricted stock units outstanding at December 31, 2017

 

941,017

 

 

0.94

 

Restricted stock units expected to vest beyond December 31, 2017

 

940,994

 

$

0.93

 

 

Schedule of additional information on restricted stock units

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

December 31,

 

December 31,

 

 

 

2017

    

2016

    

2017

    

2016

 

Restricted stock compensation expense (in thousands)

 

$

102

    

$

165

 

$

389

    

$

540

 

Aggregate fair value of restricted stock units vested and issued (in thousands)

 

$

19

 

$

25

 

$

156

 

$

132

 

Weighted average grant date fair value of restricted stock units granted during the period

 

$

0.89

 

$

0.91

 

$

0.76

 

$

1.64

 

 

Schedule of restricted stock award activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

December 31,

 

December 31,

 

 

    

2017

    

2016

    

2017

    

2016

 

Restricted stock awards compensation expense (in thousands)

 

$

 —

 

$

 1

 

$

 3

    

$

102

 

Restricted stock awards granted

 

 

 —

 

 

1,389

 

 

3,969

 

 

63,500

 

Weighted average grant date fair value of restricted stock awards granted during the period

 

$

 —

 

$

0.90

 

$

0.63

 

$

1.56